MannKind Corp (MNKD)

NASDAQ
4.800
+0.120(+2.56%)
After Hours
4.830
+0.030(+0.625%)
- Real-time Data
  • Volume:
    1,833,806
  • Bid/Ask:
    4.800/4.850
  • Day's Range:
    4.660 - 4.840

MNKD Overview

Prev. Close
4.68
Day's Range
4.66-4.84
Revenue
74.51M
Open
4.67
52 wk Range
1.78-6.25
EPS
-0.36
Volume
1,833,806
Market Cap
1.2B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,611,159
P/E Ratio
-
Beta
1.92
1-Year Change
159.46%
Shares Outstanding
249,660,178
Next Earnings Date
Nov 10, 2021
What is your sentiment on MannKind Corp?
or
Market is currently closed. Voting is open during market hours.

MannKind Corp News

MannKind Corp Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyBuy
Technical IndicatorsSellStrong BuyStrong BuyStrong BuyStrong Buy
SummaryNeutralStrong BuyStrong BuyStrong BuyStrong Buy

MannKind Corp Company Profile

MannKind Corp Company Profile

Employees
241

MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. AFREZZA utilizes its Technosphere formulation technology. The Technosphere is a drug delivery platform that allow the oral inhalation of a range of therapeutics.

Read More
  • CCXI...FDA approval July 7th! Stock is about to skyrocket. Cancer treatment Drug 🤑 Gamechanger!! Yw
    0
    • The best price to buy
      0
      • https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-and-united-therapeutics-reach-milestone-development
        0
        • GO MNKD GO
          0
          • https://mannkindcorp.com/wp-content/uploads/2021/04/Newsletter-April-2021-Final.pdf
            0
            • sold at the bottom after losing patience
              1
              • https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-and-united-therapeutics-reach-milestone-development
                0
                • MA50 broken, a close above 4.333 would be fine.
                  0
                  • Up up up
                    0
                    • I believe in you
                      0
                      • we see what happens
                        0
                        • potential stock is here, MNKD. shout out to MNKD holders.
                          0
                          • MNKD is next
                            0
                            • hiii
                              0
                            • please suggest me in trades
                              0
                            • please suggest me in trades
                              0
                          • BUY MNKD
                            0
                            • help in trades
                              0
                          • big rally needed today...go MNKD!
                            0
                            • looking good for pulmonary hypertension, inhaled insulin and thyroid  up, up,up we go
                              0
                              • any news from folks in the medical field
                                0
                                • keep moving
                                  0
                                  • Any negative news for Mannkind?
                                    1
                                    • Gild inhaled remdesivir
                                      0
                                      • we haven't even seen TRE-T partnership with UTHR included with MNKD.
                                        0
                                        • is mannkind a buy
                                          0
                                          • slowly...Feb 26
                                            0
                                            • asik olma bu kaada, ben bunu ).65 ten alip $8 dan sattigimi biliyorum... tamamen spec bu kaat
                                              0
                                          • I am waiting for an increase before earning
                                            0
                                            • I am waiting for the exit before earning
                                              1
                                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.